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Abstract 
The aim of this research was to investigate the molecular interactions occurring in the 
formulation of non-ionic surfactant based vesicles composed Monopalmitoyl glycerol (MPG), 
Cholesterol (Chol) and Dicetyl Phosphate (DCP). In the formulation of these vesicles, the 
thermodynamic attributes and surfactant interactions based on molecular dynamics, Langmuir 
monolayer studies, differential scanning calorimetry (DSC), hot stage microscopy and 
thermogravimetric analysis (TGA) were investigated. Initially the melting points of the 
components individually, and combined at a 5:4:1 MPG:Chol:DCP weight ratio, were 
investigated; the results show that lower (90 °C) than previously reported (120 to 140 °C) 
temperatures could be adopted to produce molten surfactants for the production of niosomes. 
This was advantageous for surfactant stability; whilst TGA studies show that the individual 
components were stable to above 200 °C, the 5:4:1 MPG:Chol:DCP mixture show ~2 % 
surfactant degradation at 140 °C, compared to 0.01 % was measured at 90 °C. Niosomes 
formed at this lower temperature offered comparable characteristics to vesicles prepared using 
higher temperatures commonly reported in literature. In the formation of niosome vesicles, 
cholesterol also played a key role. Langmuir monolayer studies deomonstrated that 
intercalation of cholesterol in the monolayer did not occur in the MPG:Chol:DCP (5:4:1 weight 
ratio) mixture. This suggests cholesterol may support bilayer assembly, with molecular 
simulation studies also demonstrating that vesicles cannot be built without the addition of 
cholesterol, with higher concentrations of cholesterol (5:4:1 vs 5:2:1, MPG:Chol:DCP) 
decreasing the time required for niosome assembly.  
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1. Introduction 
Non-ionic surfactant vesicles (NISV) or niosomes are generally prepared from non-ionic 
surfactants such as e.g. monopalmitoyl glycerol, sorbitan esters or ethoxylated sorbitan esters, 
combined with cholesterol and often charged lipids such as dicetyl phosphate or stearylamine 
(Uchegbu and Florence, 1995, Brewer and Alexander, 1992, Carafa et al., 1998, Manosroi et al., 
2003). Niosomes, like liposomes, have been investigated to enhance the delivery of a range of 
drugs and vaccines (Uchegbu et al., 1995, Uchegbu and Florence, 1995, Wilkhu et al., 2013b). 
For example, work from our laboratories have investigated their ability to enhance vaccine 
efficacy for antigens such as subunit influenza H1N1, H3N2 (Wilkhu et al., 2013a, Wilkhu et 
al., 2013c) and malarial antigens Merozoite surface protein 1 (MSP1) and glutamate rich protein 
(GLURP) (Vangala et al., 2006, Wilkhu et al., 2013a, Wilkhu et al., 2013c). We have recently 
considered the in vivo fate of such antigen-loaded niosomes and our results demonstrate that 
incorporation of antigen within vesicles enhanced delivery and targeting of the antigen to the 
Peyer’s Patch compared to antigen alone. Delivery to both the Peyer’s patches and mesentery 
lymphatics was shown to be dose dependent at lower concentrations, with saturation kinetics 
applying at higher concentrations(Wilkhu et al., 2013a). 
 
In the production of niosomes, melting of the surfactants and subsequently homogenising them 
into an aqueous phase can be used (Uchegbu, 2000); however, quoted melting temperatures 
used in many of these protocols is high and based on the individual melting points of each of 
the surfactants used. For example, in the preparation of niosomes composed of monopalmitoyl 
glycerol (MPG), cholesterol and dicetyl phosphate (DCP) temperatures of 120 to 140 °C have 
been used (Mann et al., 2004, Mann et al., 2009). Yet, high temperatures may cause surfactant 
degradation; therefore, consideration of the required temperatures employed in such protocols 
is a vital component in niosome formulation studies.  
To understand further the properties of surfactants used to build niosomes, a range of methods 
can be adopted. For example, Differential Scanning Calorimetry (DSC) has been widely used 
in its application in understanding the thermal characteristics of materials (Bouzidi et al., 2005) 
where an insight into a range of thermal properties including melting temperatures, phase 
transitions and heat capacity changes can be obtained. Thermogravimetric analysis (TGA) can 
also be employed to understand thermal degradation and lipid/surfactant decomposition when 
elevating the temperature of the sample (Skala et al., 1997).   
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To consider the organisation of surfactants into niosomes, molecular modelling techniques can 
also be used to mimic the behaviour of molecules on an atomic level (Cai et al., 2011). 
Currently there are numerous reports in the field of lipid simulations and progress in this area 
has been summarised in recent reviews (Bennett and Tieleman, 2013, Rabinovich and 
Lyubartsev, 2013, Schneck and Netz, 2011, Lyubartsev and Rabinovich, 2011, Notman and 
Anwar, 2013). All-atomic molecular dynamics (MD) simulations are capable of providing the 
detailed information of each atom in the simulated lipid systems based on an empirical force 
field (e.g. GROMOS, CHARMM, AMBER), which is hard to obtain otherwise (Cai et al., 
2011). Currently, all-atomic MD simulations are able to simulate these systems with hundreds 
of lipids and water from the order of several nanoseconds to hundreds of nanoseconds (Bennett 
and Tieleman, 2013, Notman and Anwar, 2013).  
Given that previous work from our laboratories has investigated using niosomes for the 
delivery of vaccines using a surfactant combination of MPG:Chol:DCP at a 5:4:1 wt ratio 
(Wilkhu et al., 2013c, Wilkhu et al., 2013a), the aim of this current work was to investigate the 
thermal conditions required for the production of non-ionic based vesicles prepared via hot-
melt homogenisation and to consider the molecular interactions in the system, via MD 
simulations, with particular consideration of the role of cholesterol within the system.  
2. Materials and Methods 
2.1 Surfactants 
The surfactants used in the study were Monopalmitoyl glycerol (MPG) (Larodan Labs, 
Sweden), Cholesterol (Synthecol) (Sigma Aldrich, UK) and Dicetyl Phosphate (DCP) (Sigma 
Aldrich, UK).  
2.2 Differential scanning calorimetry investigations of surfactants and surfactant blends 
The surfactants were analysed in the solid state using a TA Instruments Q200 Thermal Analysis 
DSC. The DSC was calibrated using sapphire and indium for a cell constant and temperature 
calibration based on the heat flow and type of cooler in place on the system. The individual 
surfactants were weighed into T-Zero aluminium pans and then hermetically sealed. All 
experimental runs started at an initial temperature of 20 °C, purged under nitrogen gas, with a 
scan rate of 10 °C /minute to 120 °C. 
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After the individual surfactants were analysed for melting, different blends of the surfactant 
mixtures were further analysed based on a design of experiments template created where the 
ratio of surfactants was changed. The surfactants were mixed at the appropriate ratios and a 
sample of this blend was placed into the pan and investigated.  
2.3 Thermogravimetric analysis of surfactant blends 
The three surfactants (MPG, Chol and DCP), either individually or at a 5:4:1 ratio, were placed 
onto the Perkin Elmer TGA and analysed for their stability across a temperature range of 20 to 
250 °C. Samples were also heated to 90 °C, 120 °C or 140 °C and held isothermally for 10 
minutes at each of the three temperatures respectively to consider the stability at melting 
commonly reported (Mann et al., 2004, Mann et al., 2009). All samples were run in triplicate 
to determine degradation and reproducibility, and all formulations were carried out using 
nitrogen gas and air. 
2.4 Design of Experiments 
To afford better understanding of the temperatures required to melt the surfactants employed 
in the preparation of MPG:Cholesterol:DCP niosomes, further studies adopting Design of 
Experiments using a D-optimal design were employed. The MPG ratio was fixed at a wt ratio 
of 5 whilst cholesterol varied from a wt ratio of 2-4 and the DCP wt ratio from 0-3, hence 
effects of the individual components could be analysed for melting onset temperature, melting 
enthalpy, crystallisation enthalpy and reheat enthalpy.  
2.5 Investigation of surfactant packing in monolayers 
Langmuir monolayer studies have been used widely to understand the packaging of surfactants 
when mixed together by spreading insoluble amphiphilic molecules in chloroform onto an 
aqueous water subphase (Gopal and Lee, 2006). Monolayer studies of the individual surfactants 
(MPG, Chol and DCP), and a mixture of surfactants in the ratio 5:4:1 of MPG:Chol:DCP 
respectively, were carried out using a KSV mini trough Langmuir system (KSV Instruments 
Ltd, Helsinki, Finland) equipped with a platinum Wilhelmy plate in an isolated area. Ultrapure 
water 18 Ω (Milipore, UK) formed the subphase within these studies and the temperature of 
the trough was 20 ± 1 °C. Stock solutions of the individual surfactants were prepared at a 0.5 
mg/mL in chloroform and a mixture was also prepared in chloroform at the set ratio. The 
method used was adapted from Ali et al, (2010) where 20 µL of the surfactant stock solutions 
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was spread onto the air/water interface using a glass Hamilton syringe precise to ± 0.2 µL (Ali 
et al., 2010). Upon spreading of the samples onto the interface, the chloroform was left to 
evaporate and the hydrophilic barriers were set to close at a speed of 10 mm/min to form 
monolayer isotherms. Each sample ran until it reached its collapse pressure and triplicate 
samples were tested. 
2.6 Simulation of Molecular Dynamics 
The molecular dynamics (MD) simulations utilized the AMBER11 software package (Case et 
al., 2005) with the general AMBER force field (gaff) (Wang et al., 2005) for all molecules. All 
molecules and models were built by Discovery Studio Visualizer 3.1.  For simulation of the 
melt process, the simulated annealing method was used to mimic the hot melt preparation 
method of solid dispersion in the experiments (Ouyang, 2012). In the minimisation procedure, 
the structures were subjected to 1000 steps of steepest descent minimisation followed by 1000 
steps of conjugate gradient minimization. After minimisation, 1 ns simulated annealing 
simulation was performed. Langevin dynamics was used with a time step of 2 fs and a cut off 
of 12 Å for non-bonded interactions. Firstly, the system was gradually heated from 0 to 400 K 
in 200 ps, and then kept at a temperature of 400 K for 300 ps to equilibrate the systems. Next, 
the system was cooled from 400 to 300 K in 100 ps and finally the systems were kept at a 
temperature of 300 K for 400 ps for equilibration. The simulated annealing procedure was 
repeated 10 times (10 ns) for complete convergence of the systems.  
For the simulation of lipid molecules in water, a classical MD simulation was performed. The 
electrostatic interactions were calculated with the particle mesh Ewald method (Darden et al., 
1993, Essmann et al., 1995, Crowley et al., 1997, Sagui and Darden, 1999, Toukmaji et al., 
2000, Sagui et al., 2004) and the cut off was 10 Å. Using the LEAP module in AmberTools 
1.5, the lipid structure was immersed in a truncated octahedral water box with a solvation shell 
of 10 Å thickness using TIP3P model for water (Jorgensen et al., 1983). This procedure resulted 
in solvated water structures containing approximately 30,000 atoms which included the above 
lipid molecules, with the remainder being water molecules. The simulation protocol with 10 ns 
was the same as previous publications (Ouyang et al., 2010a, Ouyang et al., 2010b, Ouyang et 
al., 2011). 
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2.7 Preparation of non-ionic surfactant based vesicles 
To prepare the bilayer vesicles, the surfactants in the powder form (307.5 mg) were mixed at 
the appropriate ratio (5:4:1 of MPG:Chol:DCP respectively), melted in an oil bath at the 
appropriate temperature (90, 120 or 140 °C depending on the experiment) for 10 minutes. 
While maintaining the molten lipid mix, vesicles were created by the addition of 5.45 mL of 
25 mM sodium bicarbonate (Sigma Aldrich, UK) buffer pH 7.6 (60 °C) and homogenised for 
5 minutes using a Silverson machines homogeniser model #L4RT. After 5 minutes, a pre-
incubated (60 °C) solution of OVA (1 mg/mL; 0.55 mL) was added to the vesicles and further 
homogenised for 5 minutes. Upon cooling, the niosome formulation was incubated for 2 hours 
in an incubating mini-shaker (VWR) with gentle shaking at 220 rpm.  
2.8 Determination of vesicle size and zeta potential 
The vesicle size distribution was determined using laser diffraction on a sympatec 2005 
(Helos/BF) cuvette analyser. 20 µL of the niosome suspension was diluted into the cuvette with 
40 mL double distilled water. The zeta potential, which is an indirect measurement of the 
vesicle surface charge, was measured in 1.5 mL double distilled water at 25 °C on a Zeta Plus 
Brookhaven Instrument. 15 µL of the niosome suspension was mixed in 1.5 mL double distilled 
water and then analysed.  
2.9 Determination of OVA entrapment 
The OVA loading was determined in the vesicles after separation via centrifugation, produced 
by the addition of 300 µL of the niosome sample in a 3.9 mL Beckman centrifuge tube filled 
with double distilled water for a period of 40 minutes at 354,000 X g (TLN-100 rotor). The 
protein content of niosomes was measured directly using the Ninhydrin assay at a wavelength 
of 560 nM (Brewer et al., 1995). 
3. Results  
3.1 Cholesterol dissolution in the lipid melts promotes lower melting temperature 
requirements for niosomes production. 
To investigate the thermal characteristics of the surfactant mixtures used in the production of 
niosomes, the individual surfactants and their physical mix blend were investigated by 
differential scanning calorimetry to determine their melting properties both independently and 
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as a blend. Figure 1A, represents the thermograms of the individual components, and a mixture 
blend of MPG:Chol:DCP at a 5:4:1 wt ratio of respectively, all in the solid state. From figure 
1A, DCP has a melting onset temperature of 74.2 ± 0.3 °C with a Tmax of 77.3 °C, followed 
MPG (melting onset of 74.9 ± 0.2 °C with a Tmax of 79.1 °C), and finally cholesterol which 
had the highest melting point of 148.7 ± 0.07 °C with a Tmax at 150.1 °C. However, when 
these three lipids were mixed at a 5:4:1 weight ratio (MPG:Chol:DCP), the mixture has a 
melting onset temperature of 72.3 ± 0.7 °C with a complete melt (Tmax) at 79.4 °C (Figure 
1A) with no further thermal events occurred after this temperature (data not shown).  
Hot stage microscopy was used to further investigate the melting of the surfactant blend. The 
hot stage was set with start and end temperatures the same as those adopted in the DSC; 
however, a slightly slower scan rate (6 °C/ min) were employed due to the resolution and 
accuracy of the recording software. Figure 1A shows two image reels, one of cholesterol alone 
and one of a MPG:Cholesterol:DCP (5:4:1 wt ratio) powder blend with cholesterol in contact 
with MPG and DCP. As can be seen, cholesterol on its own does not melt until 148-150 °C. 
However, the mixture represented in Figure 1A shows that just before the complete melt 
(Tmax) at 80 °C there are still crystals present and that complete melting occurs at 81 °C which 
corresponds to the DSC thermogram of the mixture (Figure 1A). These results suggest that 
cholesterol may be dissolving into the molten MPG/DCP mixture.  
 
To further investigate if cholesterol melted or solubilised within the solid state lipid mixture 
upon heating, hyper DSC was used on the surfactant mixture MPG:Chol:DCP (5:4:1 wt ratio) 
to try to separate the thermodynamic events from any kinetic events (Figure 1B). Faster heating 
rates are employed to provide insufficient time for dissolution/solubilisation to take place, 
therefore should represent clear endotherm peaks at the melting points of the individual 
components (Gramaglia et al., 2005). The results from the hyper DSC give rise to a large broad 
melting peak which contains multiple peaks representing the surfactant mixture, with no 
presence of a melting peak at the cholesterol melting point temperature (149 °C; Figure 1B), 
indicating that cholesterol integration has taken place prior to its melt. Unfortunately, figure 
1B indicates that a scan rate of 500 °C/min was not sufficient to circumvent dissolution of 
cholesterol occurring in the mixture.   
 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. (A) Melting ofmixture andindividual surfactants overlaidonto a single scanandmelting 
onsettemperatures andcorrespondingmelting enthalpies for the individual surfactants and their 
mixtures (region of 25–160◦C with a scan rate 10◦C/min). Hot stage microscopy images of 
cholesterol and the 5:4:1 MPG:Chol:DCP mixture are also shown (scan rate of 6◦C/min). (B) 
Hyper DSC thermogram of the surfactant mixture in the region of 0–200◦C at a scan rate of 
500◦C/min. 
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The impact of the surfactant mixture composition on the resulting melting points required to 
form niosomes was considered in a Design of Experiments study; results (Figure 2) showed 
that when the ratio of cholesterol was increased relative to DCP, the onset of melting point 
decreases (Figure 2A). This trend correlates with a decrease in enthalpy, which takes place 
when cholesterol content increases within the mixture (Figure 2B). Similarly, at fixed 
cholesterol content, increasing DCP content increased the melting enthalpy (Figure 2B). When 
the cholesterol content increases, the heat enthalpy required to break the bonds and allow for 
melting of the mixture decreases, as further represented in figure 2C. Figure 2C demonstrates 
that the cholesterol lowers the melting onset, which can be due to its effect on lowering the 
heat energy required to melt the mixture. When cholesterol content is increased, the heat 
enthalpy required (which is used to break the bonds and allow for melting to occur) decreases. 
Again, this suggests that the cholesterol is not melting, but is dissolving into the molten 
mixture, therefore allowing the mixture to melt at a lower temperature as visualised by the hot 
stage microscopy (Figure 1A). 
3.2 Reducing surfactant degradation through reduced preparation temperatures 
Given the results from DSC analysis (Figures 1 to 3) suggest that lower temperatures than 
previously reported for the formulation of MPG-based niosomes (e.g. Skala et al., 1997) may 
be employed, thermal gravimetric analysis of the components was conducted to consider the 
stability (in terms of weight loss) of the surfactants at different temperatures. TGA isotherms 
of the individual surfactants (MPG, cholesterol and DCP) from 30 °C to 250 °C are shown in 
Figure 3A. The results show that for the three individual surfactants, there is no measured 
weight loss until temperatures are in excess of 180 °C (Figure 3A) which exceeds the working 
temperature range commonly reported in the manufacture to produce niosomes. However, 
when MPG, Cholesterol and DCP are combined into a 5:4:1 wt ratio mixture (Figure 3A; 5:4:1 
mix), the surfactant mixture shows degradation at temperatures lower than the individual 
components, with changes in weight being measured at around 120 °C (Figure 3A). To further 
investigate this, the 5:4:1 blend of MPG:CHO:DCP  was held isothermally for 10 minutes at 
three melting range temperatures 90, 120 and 140 °C and weight loss recorded (Figure 3B). 
The results show that when the surfactant blend was held at 120 and 140 °C (temperatures 
adopted in previously reported niosome formulation protocols e.g. Mann et al., 2004, Mann et 
al., 2009) there was measured weight loss of 0.6 ± 0.3 % and 2.3 ± 0.9 % respectively (Figure 
3B). However, by adopting a temperature of 90 °C, which was shown to promote the melting 
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of the surfactant powder mix (Figure 1), notably lower weight loss was measured (0.01 ± 
0.0015 %; Figure 3B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Contourplots showingthe thermodynamic effects of DCP and cholesterol upon 
melting.(A)The effectof cholesterol and DCP on the onset of melting(◦C), (B) the effect of 
cholesterol and DCP on the melting enthalpy (J/g) of the mixture. MPG surfactant kept constant 
ratio of 5 for each ratio of DCP and cholesterol varied (scan rate = 10◦C/min) and (C) Main 
effects plot for the effect of cholesterol content upon melting enthalpy of the system (J/g). 
 
A B 
C 
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3.3 Adopting lower temperatures for the production of niosomes 
Based on the information obtained about the surfactant mixtures in Figures 1 to 3, vesicles 
were produced at two temperature ranges with an oil bath either set between 90-95 °C or 120-
125 °C and upon manufacture, the niosomes were investigated to elucidate if lower 
temperatures could be adopted in their manufacture. Two sets of formulations were prepared: 
‘empty’ niosomes alongside niosomes formulated with the model antigen, OVA, as these 
vesicles as commonly investigated as vaccine delivery systems. The average vesicle size, zeta 
potential and entrapment for formulations are presented in Table 1. An average vesicle size of 
~ 6 µm was produced irrespective of the temperature used to melt the surfactants (Table 1).  
Similarly, there is no notable difference in zeta potential or OVA loading ( ~23 % of initial 
amount added; 550 µg) between the two methods of preparation suggesting that the lower 
temperature production method can be used in the hot-melt homogenisation production of 
niosomes. 
3.4 Surfactant packing studies: the impact of cholesterol 
To consider how cholesterol may influence the packing of the surfactants in the bilayer 
vesicles, monolayer isotherms for the individual surfactants and the mixture of the surfactants 
were investigated, and the experimental and ideal extrapolated mean molecular area and 
surface area compression pressure of mixed and pure monolayers at the air/water interface 
measured (Figure 4).  
The scan of MPG (Figure 4) shows that the surfactant isotherm exhibits several phase changes 
prior to collapsing when the surface pressure is increased. At 65 - 50 A2/molecule there is a 
gaseous phase, followed by a liquid expanded and gaseous phase from 50 - 35 A2/molecule. At 
35 - 22 A2/molecule a liquid condensed/ liquid expanded phase is present followed by a short 
liquid condensed phase to 20 A2/molecule where a sharp solid phase up to 16 A2/molecule and 
the surface collapse pressure of 51.6 ± 1.5 mN/m is reached. In terms of cholesterol (Figure 4) 
the phase changes upon increasing surface pressure differ to those of the MPG surfactant; 
cholesterol starts in a gaseous phase from 40 - 35 A2/molecule followed by liquid condensed 
phase from 35 - 30 A2/molecule. After 30 A2/molecule a sharp solid phase occurs up to 27 
A2/molecule at a surface collapse pressure of 46.6 ± 0.5 mN/m. The DCP isotherm is very 
similar to that of cholesterol, where a gaseous phase exists between 40 - 50 A2/molecule until 
a liquid condensed phase is achieved between 36 - 40 A2/molecule until a final collapse 
pressure is reached of 53.8 ± 0.9 mN/m at 34 A2/molecule.
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Fig. 3. (A) Thermogravimetric analysis scans ofthe individual surfactants and of a 5:4:1 blend 
of MPG:Chol:DCP respectively from 20 to 250◦C and (B) thermogravimetric scans of the 5:4:1 
MPG:Chol:DCP blend at three melting range temperatures held isothermally for 10 min all at 
a scan rate of 10◦C/min. 
MPG 
Cholesterol 
DCP 
5:4:1 mix 
A 
B 
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The MPG:Chol:DCP mixture (5:4:1 weight ratio) was also investigated (Figure 4); the mixture 
exhibits a gaseous phase from 31 - 38 A2/molecule where a liquid condensed phase occurs at 
28 - 31 A2/molecule followed by a sharp solid condensed phase at 24 A2/molecule with a 
collapse pressure of 51.9 ± 0.1 mN/m (Figure 4). When extrapolating the mean molecular area 
at zero surface pressure for the mixture, there was no significant difference between the 
calculated ideal extrapolated molecular area at zero pressure and that measured experimentally 
(28.3 ± 1.5 A2/molecule compared with 29.2 ± 0.2 A2/molecule respectively; Figure 4).  
Table 1 Initial vesicle size, zeta potential and antigen entrapment for the stability study 
 
Temperature (Ova NISV) Temperature (empty NISV) 
   95 °C    120 °C    95 °C    120 °C 
Size (μm)   6.15 ± 0.1     6.52 ± 0.5   6.25 ± 0.04   6.58 ± 0.25 
Span   1.73 ± 0.08      1.73 ± 0.05   1.81 ± 0.02   1.76 ± 0.01 
Zeta potential (mV) −63.2 ± 9.5   −61.7 ± 8.4 −81.5 ± 9.4 −80.2 ± 9.5 
Ova entrapment (%)   23.5 ± 2.1    23.3 ± 1.2   
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Langmuir monolayer isotherms showing surface pressure as a function of mean 
molecular area representing individual surfactants and MPG:Chol:DCP (5:4:1 weight ratio) 
including the experimental and ideal extrapolated mean molecular area and surface area 
compression pressure of mixed and pure monolayers at the air/water interface (at 20◦C). 
 16 
 
3.5 Simulation of surfactant interactions using molecular dynamics 
Molecular modelling techniques are able to describe the complex systems on an atomic level 
and there are a number of studies on lipid structures by molecular simulation techniques 
(Lyubartsev and Rabinovich, 2011, Berkowitz, 2009). Within the preparation of niosomes, the 
lipid mixture was heated and melted in an oil bath. Thus, a simulated annealing technique in 
the modelling was used to investigate the molecular interaction by simulating the melting 
procedure. The simulated annealing procedure (Figure 5A) can represent the temperature 
change (heat to high temperature, maintained high temperature, and cool to room temperature) 
of the niosome production process used. After completing 10 simulated annealing cycles for 
the complete convergence of the systems, Figure 5B demonstrates that under heat, MPG 
molecules cannot bind together without the presence of cholesterol, whilst MPG with 
cholesterol and DCP can effectively mix and interact together in the melting process. 
Moreover, in the simulation, the MPG:Chol:DCP mixture at the ratio of 5:4:1 reaches 
equilibrium more easily than that of 5:2:1 (data not shown). 
Similar results are also observed from the simulations in aqueous environment; Figure 6 shows 
that MPG:Chol:DCP at the ratio of 5:4:1 only needs about 500 ps to reach equilibrium, whilst 
reducing the cholesterol content to a  ratio of  5:2:1 needs four-fold longer (about 2 000 ps) to 
acquire the equilibrated state (Figure 6), again demonstrating the supporting role of cholesterol 
in the formulation and construction of these niosome systems. Furthermore, as Figure 7 
indicates, that the MPG alone cannot form a stable system even after 10 ns.  
4. Discussion 
In general, the formation of non-ionic surfactants into bilayer vesicles is dependent on many 
factors including: temperature, surfactant choice and concentration, electrostatic and 
electrodynamic interactions of the surfactants within the aqueous phase. Interestingly in our 
studies (Figures 1 – 3) we have demonstrated that the choice of surfactant blend, in particular 
incorporation of cholesterol, influences the thermal attributes of the surfactant blends, both in 
the initial melting of the surfactants and in formed vesicle bilayers in the aqueous phase. Our 
studies demonstrate that in the formulation of niosomes where MPG, Chol and DCP surfactants 
are melted, the cholesterol itself does not melt; rather, it becomes miscible with the molten 
MPG/DCP mixture.  
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Fig 5(A) Temperature change vs time for the lipid systems in a simulated annealing cycle. (B) 
Snapshots of lipid systems in the simulated annealing simulations. MPG systems: (i) 0 ps from 
the front view, (ii) 0 ps from the top view, (iii) 10 ns; lipid system at the ratio of 5/2/1: (iv) 0 ps 
from the front view, (v) 0 ps from the top view, (vi) 10 ns; lipid system at the ratio of 5/4/1: 
(vii) 0 ps from the front view, (viii) 0 ps from the top view, (ix) 10 ns. (Light blue colour 
represents MPG molecule; dark blue colour represents CHO molecule; white colour represents 
DCP molecule.). (For interpretation of the references to color in this figure legend, the reader 
is referred to the web version of the article.) 
MPG 
MPG:Chol:DCP 
5:2:1 
MPG:Chol:DCP 
5:4:1 
0 ps, Front view 0 ps, Top view 10 ns 
i)           ii)          iii) 
iv)           v)                 vi) 
vii)            viii)           ix) 
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Fig. 6. The radius of gyration, with fluctuation as a function of time for both simulations: red 
(ratio of 5:2:1; MPG:Chol:DCP) and black (ratio of 5:4:1; MPG:Chol:DCP).(For interpretation 
of the references to color in this figure legend, the reader is referred to the web version of the 
article.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Snapshots of lipid systems in the aqueous environment: (a) 10 ns of MPG systems; (b) 
10 ns of lipid system at the weight ratio of 5:2:1; (c) 10 ns of lipid system at the weight ratio 
of 5:4:1. Light blue colour represents MPG molecule; dark blue colour represents CHO 
molecule; white colour represents DCP molecule. (For interpretation of the references to color 
in this figure legend, the reader is referred to the web version of the article.) 
 
 
A                  B                  C 
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This is supported by the molecular dynamic studies in Figure 5, which show that cholesterol 
mixes with the MPG and DCP molecules in the melting process. Studies by Brostow and 
Datashvili, (2007) show that melting point depression of low density polyethylene occurs upon 
addition of different ratios of melamine formaldehyde indicating miscibility between the two 
components (Brostow and Datashvili, 2007). Furthermore, the increase in cholesterol ratio 
results in a greater surface area of cholesterol within the mixture and interferes with the MPG 
and DCP lipid matrix which results in interference with the crystalline structures, hence further 
reducing the enthalpy of melting. DSC, and hot-stage microscopy results confirm that the 
cholesterol is able to dissolve into the molten MPG/DCP mixture and that this acts as a solvent 
for the cholesterol to dissolve in. Overall, these findings show that when manufacturing at a 
large scale, the order of addition of the components could increase melting efficiency by 
enabling melting to take place at lower temperatures, in turn reducing the risk of thermal 
degradation of the surfactants. Within this study, we have also demonstrated that lower 
temperatures can be employed to melt surfactant mixtures and form niosomes (Table 1). 
 
The molecular attributes of the surfactant is also an important parameter in niosome formation, 
as the type of colloidal or vesicular structure a specific surfactant forms is to a large extent 
dictated by its molecular shape and the mixture of surfactant combinations used, as this will 
influence its geometrical packing properties in a given solution environment. The shape of a 
surfactant may be expressed as its critical packing parameter (CPP), which is a measure of the 
overall geometry of a surfactant molecule. This can be used a predictor of the resultant 
structures they can form:  a CPP < 0.5 indicates a large contribution from the hydrophilic head 
group area of the molecule and that such surfactant will form spherical micelles, whilst 
surfactants with a value between 0.5 < CPP < 1 forms bilayer vesicles, and a CPP > 1 
(indicating a large contribution from the hydrophobic group volume) results in inverted 
micelles (Uchegbu and Vyas, 1998, Israelachvili and Mitchell, 1975, Israelachvili et al., 1977, 
Wilkhu et al., 2013b).  
It is interesting to note that many single chain surfactants have CPP < 0.5 and form micelles, 
yet these are often used to formulate niosomes; however, not without the addition of additional 
components. For example, soluble surfactants (such as solulan C-24 and polysorbate 20) with 
high hydrophilic-lipophilic balance values readily form micelles. Yet with the inclusion of 
cholesterol into the mixture, niosome vesicle structures are formed (Uchegbu and Florence, 
1995, Manosroi et al., 2003, Carafa et al., 1998). The ability of cholesterol to promote the 
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formation of two-phase bilayer systems, rather than single phase micellar solutions, is related 
to the overall CPP of the lipid mixture. When a mixture of surfactants and additives (such as 
cholesterol) are used to prepare vesicles, the operational CPP values will consider the average 
of the overall components (Kumar, 1991). Indeed, Manosroi et al, (2003) have confirmed that 
as cholesterol is incorporated within a Tween 61 surfactant mixture, an average CPP value 
between 0.5 - 1 was obtained, hence the formation of bilayer vesicles rather than micelles 
(Manosroi et al., 2003). Similarly, Tween 20 has a CPP below 0.5; however, when mixed with 
cholesterol, unilamellar vesicles were formed (Carafa et al., 1998) as does Span 60, which is 
widely used in the formulation of niosomes (Ning et al., 2005, Uchegbu et al., 1995). This is 
due to the average CPP of the mixture moving into the range of 0.5-1, hence showing 
capabilities of forming bilayer vesicles (Wilkhu et al., 2013b).  
Cholesterol is also recognised for its ability to enhance the stability of vesicles (Gregoriadis 
and Davis, 1979). This has been attributed to the ability of cholesterol to increase the packing 
density of phospholipid membranes (Semple et al., 1996)which is thought to result from the 
accommodation of cholesterol within molecular cavities formed by surfactant monomers 
assembled into vesicles (Devaraj et al., 2002). This was shown in monolayer studies where a 
decrease in effective area per molecule with increasing cholesterol content was noted 
(Rogerson et al., 1987, Moghaddam et al., 2011). Unlike the reported intercalation of 
phospholipids and cholesterol (Ali et al., 2010), no condensing of a MPG:Chol:DCP monolayer 
was seen in these current studies (Figure 4). This correlates with the proposal that the inclusion 
of cholesterol in this niosome formulation helps to increase the overall CPP of the system, as 
intercalation of cholesterol within the system would be counterproductive, reducing the 
average area per molecule and reducing the overall CPP.  
This was supported further by molecular dynamic studies (Figure 5 -7) which demonstrated the 
beneficial role of cholesterol in the formation of niosomes. These studies show that niosome 
vesicles cannot be built from a MPG:DCP mixture, and that cholesterol was required with 
higher concentrations of cholesterol (5:4:1 vs 5:2:1 MPG:Chol:DCP) decreased the time 
required for niosome assembly. 
5. Conclusion 
Overall, this study demonstrates for the first time that, not only can cholesterol aid the initial 
melting of surfactants to form niosomes, but also that cholesterol supports the arrangement of 
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non-ionic surfactants into bilayer vesicles, potentially through cholesterol increasing the 
overall CPP of the surfactant mixture. This was supported by the use of molecular dynamics, 
which was able to simulate the behaviour of lipids upon melting, and in an aqueous 
environment. Based on these studies we were able to successfully formulate niosomes at 
reduced temperatures thereby reducing thermal degradation of the surfactant and demonstrate 
the supportive role of cholesterol within building of niosomes.  
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